학술논문

Mice fed fish oil diet and upregulation of brown adipose tissue thermogenic markers.
Document Type
Article
Source
European Journal of Nutrition. Feb2016, Vol. 55 Issue 1, p159-169. 11p.
Subject
*ADIPOSE tissues
*ANIMAL experimentation
*BODY temperature regulation
*BODY weight
*CALORIMETRY
*CYTOKINES
*DOSE-effect relationship in pharmacology
*ENERGY metabolism
*FISH oils
*FLUORESCENT antibody technique
*FAT content of food
*GLUCOSE tolerance tests
*HISTOLOGICAL techniques
*HYPERCHOLESTEREMIA
*INGESTION
*MICE
*POLYMERASE chain reaction
*PROBABILITY theory
*RESEARCH funding
*RESPIRATORY quotient
*STATISTICS
*TRIGLYCERIDES
*LEPTIN
*DATA analysis
*REVERSE transcriptase polymerase chain reaction
*GLUCOSE intolerance
*DATA analysis software
*PEROXISOME proliferator-activated receptors
*DESCRIPTIVE statistics
*ONE-way analysis of variance
*IN vivo studies
Language
ISSN
1436-6207
Abstract
Purpose: Fish oil (FO) elicits diverse beneficial effects. Reduction in or prevention of body mass (BM) gain in animal models may be associated with modulation of brown adipose tissue (BAT). We aimed to evaluate the effects of different high-fat diets with FO on BAT metabolism and thermogenic markers. Methods: C57BL/6 male mice (3-month-old) were fed different diets during 8 weeks: standard-chow diet (SC 10 % fat), high-fat lard diet (HF-L 50 % fat), high-fat lard plus FO diet (HF-L+FO 50 % fat), and high-fat FO diet (HF-FO 50 % fat). We evaluated BM and performed an oral glucose tolerance test. At euthanasia, plasma was collected for leptin, and triacylglycerol measurement and interscapular BAT was dissected and stored for molecular analyses. Results: HF-L group showed elevated BM; glucose intolerance associated with diminished TC10 and GLUT4 expressions; hypertriglyceridemia associated with increased CD36 and diminished CPT1 expression; elevated expression of pro-inflammatory cytokines; and reduced PPAR expression. Furthermore, these animals showed hyperleptinemia with increased expression of thermogenic markers (beta3-AR, PGC1alpha, and UCP1). Conversely, HF-L+FO and HF-FO groups showed reduced BM gain with regularization of glucose tolerance and triglyceridemia, GLUT4, TC10, CD36, CPT1, and cytokines expressions. Both groups exhibited elevated PPAR and thermogenic markers expression in a dose-dependent way. Conclusions: FO improves metabolic profile and upregulates thermogenic markers, suggesting an elevated thermogenesis that leads to reduced BM gain. [ABSTRACT FROM AUTHOR]